<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Market Chatter: Novo Nordisk&#x27;s Wegovy Delivers Increased Weight Loss in Triple-Dose Trials — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Market Chatter: Novo Nordisk&#x27;s Wegovy Delivers Increased Weight Loss in Triple-Dose Trials</h2>
    <div class="badge">2025-09-15T10:26:08+00:00</div>
    <ul>
      <li>A Silver or Gold subscription plan is required to access premium news articles.</li>
<li>Market Chatter: Novo Nordisk&#x27;s Wegovy Delivers Increased Weight Loss in Triple-Dose Trials Novo Nordisk&#x27;s (NVO) obesity treatment drug Wegovy led to increased weight loss in patients during t Upgrade to read this MT News</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Market Chatter: Novo Nordisk&amp;#x27;s Wegovy Delivers Increased Weight Loss in Triple-Dose Trials\n• A Silver or Gold subscription plan is required to access premium news articles.\n• Market Chatter: Novo Nordisk&#x27;s Wegovy Delivers Increased Weight Loss in Triple-Dose Trials Novo Nordisk&#x27;s (NVO) obesity treatment drug Wegovy led to increased weight loss in patients during t Upgrade to read this MT News" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/market-chatter-novo-nordisk-apos-102608464.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>